Myopathy and hepatic lipidosis in weaned lambs due to vitamin E deficiency

by Menzies, Paula, Langs, Lisa, Boermans, Herman, Martin, John, McNally, John
Published 2004

Adverse event rates in the retrospective cohort study of safety of paediatric soft contact lens wear: the ReCSS study

by Chalmers, Robin L, McNally, John J, Chamberlain, Paul, Keay, Lisa
Published in Ophthalmic Physiol Opt (2020)

Preclinical Pharmacokinetics and First-in-Human Pharmacokinetics, Safety, and Tolerability of Velpatasvir, a Pangenotypic Hepatitis C Virus NS5A Inhibitor, in Healthy Subjects

by Mogalian, Erik, German, Polina, Kearney, Brian P., Yang, Cheng Yong, Brainard, Diana, Link, John, McNally, John, Han, LingLing, Ling, John, Mathias, Anita
Published in Antimicrob Agents Chemother (2017)

Clinical Resistance to Velpatasvir (GS-5816), a Novel Pan-Genotypic Inhibitor of the Hepatitis C Virus NS5A Protein

by Lawitz, Eric J., Dvory-Sobol, Hadas, Doehle, Brian P., Worth, Angela S., McNally, John, Brainard, Diana M., Link, John O., Miller, Michael D., Mo, Hongmei
Published in Antimicrob Agents Chemother (2016)

Efficacy and Safety of Sofosbuvir/Velpatasvir in Patients With Chronic Hepatitis C Virus Infection Receiving Opioid Substitution Therapy: Analysis of Phase 3 ASTRAL Trials

by Grebely, Jason, Dore, Gregory J., Zeuzem, Stefan, Aspinall, Richard J., Fox, Raymond, Han, Lingling, McNally, John, Osinusi, Anu, Brainard, Diana M., Subramanian, G. Mani, Natha, Macky, Foster, Graham R., Mangia, Alessandra, Sulkowski, Mark, Feld, Jordan J.
Published in Clin Infect Dis (2016)

Sofosbuvir-Based Direct-Acting Antiviral Therapies for HCV in People Receiving Opioid Substitution Therapy: An Analysis of Phase 3 Studies

by Grebely, Jason, Feld, Jordan J, Wyles, David, Sulkowski, Mark, Ni, Liyun, Llewellyn, Joe, Mir, Heshaam M, Sajed, Nika, Stamm, Luisa M, Hyland, Robert H, McNally, John, Brainard, Diana M, Jacobson, Ira, Zeuzem, Stefan, Bourlière, Marc, Foster, Graham, Afdhal, Nezam, Dore, Gregory J
Published in Open Forum Infect Dis (2018)

Sofosbuvir and Velpatasvir for the Treatment of Hepatitis C Virus in Patients Coinfected With Human Immunodeficiency Virus Type 1: An Open-Label, Phase 3 Study

by Wyles, David, Bräu, Norbert, Kottilil, Shyam, Daar, Eric S, Ruane, Peter, Workowski, Kimberly, Luetkemeyer, Anne, Adeyemi, Oluwatoyin, Kim, Arthur Y, Doehle, Brian, Huang, K C, Mogalian, Erik, Osinusi, Anu, McNally, John, Brainard, Diana M, McHutchison, John G, Naggie, Susanna, Sulkowski, Mark
Published in Clin Infect Dis (2017)